Trial NCT01600807

View at ClinicalTrials.gov 
Org. Study IDs: 11-148

Last trial update was posted on 2013-06-26

MeSH Interventions

Erlotinib Hydrochloride Gemcitabine

MeSH Conditions

Adenocarcinoma

Other Conditions

Pancreatic Cancer, Metastatic

Stopping Reasons

Study was pending major changes and was on hold, pending activation; administratively withdrawn; will be submitted as a new protocol if study is revised.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID